Term
Volume of Distribution (Vd) |
|
Definition
When the drug is distributed into all of the tissues that it is physically able to penetrate. |
|
|
Term
Water-soluble drugs (Volume of Distribution) |
|
Definition
Low Vd; higher serum levels |
|
|
Term
Lipid-soluble drugs (Volume of Distribution) |
|
Definition
High Vd; lower serum levels |
|
|
Term
|
Definition
Blood-brain barrier Prevents passage from blood to brain tissue Drugs that cross Lipid soluble Transport system Anesthetic agents, ethanol, some steroids, and some sedative-hypnotic agents |
|
|
Term
|
Definition
~Bound drug (pharmacologically inactive) Proteins serve as reservoirs ~Unbound drug (produce effect) ~Binding is reversible |
|
|
Term
|
Definition
~How the body changes the chemical structure of a drug.
~Sites of metabolism Liver (major site) GI tract, lungs, skin, and kidneys
~Body attempts to neutralize or detoxify the substance. |
|
|
Term
Biotransformation (Metabolism) |
|
Definition
Outcome of the metabolic processes |
|
|
Term
|
Definition
Resulting chemical from converted drug |
|
|
Term
|
Definition
|
|
Term
|
Definition
Contain enzymes to transform drugs (Parenchyma Contain millions of hepatocytes) |
|
|
Term
P-450 Enzyme System (Hepatic Microsomal Enzyme System) |
|
Definition
Metabolism of endogenous and exogenous substances Drugs can induce or inhibit synthesis of isoenzymes |
|
|
Term
|
Definition
A drug that increases the amount or activity of the isoenzyme. Metabolism occurs more rapidly Decrease in substrate drugs Induce/Reduce |
|
|
Term
|
Definition
Drugs that are metabolized by a specific isoenzyme |
|
|
Term
|
Definition
A drug that decreases the activity of the isoenzyme. Metabolism is decreased Increase in substrate drug
Inhibit/Increase |
|
|
Term
|
Definition
Drug metabolized before distribution
Route of administration: Oral
Drug crosses directly into hepatic portal circulation
Some drugs can be completely inactivated |
|
|
Term
|
Definition
Removal of a drug from the body |
|
|
Term
|
Definition
Kidneys Liver, GI tract, lungs, sweat and salivary glands, skin, and breast milk |
|
|
Term
|
Definition
Rate of disappearance of the drug Slow clearance High clearance |
|
|
Term
Glomerular Filtration (Renal Excretion) |
|
Definition
Low-molecular-weight molecules pass through the glomeruli Free (unbound) drugs will appear in the filtrate |
|
|
Term
Passive Tubular Reabsorption (Renal Excretion) |
|
Definition
Concentration gradient: higher concentration to lower concentration Must be lipophilic to be reabsorbed |
|
|
Term
Tubular Secretion (Renal Excretion) |
|
Definition
Active process Occurs in proximal tubule Dependent on active carriers |
|
|
Term
Renal Excretion (Factors that Affect ) |
|
Definition
pH of urine Acid drugs in basic environment: ionize Basic drugs in acidic environment: ionize Drug will not be reabsorbed Excretion increased |
|
|
Term
Renal Excretion (Factors that Affect ) |
|
Definition
Overuse of active transport system Two drugs rely on the same transport system for tubular secretion Excretion decreased |
|
|
Term
Biliary Excretion (Factors that Affect ) |
|
Definition
Enterohepatic recirculation Bile reabsorbed Excretion decreased |
|
|
Term
Respiratory Excretion (Factors that Affect ) |
|
Definition
~Respiratory activity Faster respiratory rate increases excretion ~Blood flow to lungs Increased blood flow increases excretion |
|
|
Term
|
Definition
Most drugs combine with receptors to produce their effects
Receptor Specialized area on the cell wall Drug + Receptor → Drug-receptor (binding) = Response
Receptor subtypes “fine-tuning” of pharmacology |
|
|